Today's Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?
Published Date: 28 Apr 2026

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Read More

Latest News

Merck-Eisai's Kidney Cancer Drug Combo Fail to Improve Survival in Late-stage Trial

Merck and Eisai's experimental combination treatments failed to significantly improve survival or reduce the risk of cancer ⁠progression or death in patients with the most...

Would Earlier Initiation of Clozapine Improve FEP Outcomes?

Higher response rates with clozapine after a single treatment failure raise questions about current recommendations and whether it should be used earlier in first-episode psychosis.

Hidden Bacteria Found in Common Kidney Stones

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Showing Future Heart Risks Visually Helps Patients Manage BP

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows.

Cardiometabolic Control Elusive in Adults With Hypertension

Despite new therapies, metabolic risk hasn’t improved in more than a decade.

Low eGFR Not Associated With DKA Risk in T1D

A new study supports the use of kidney-protective medication for patients with type 1 diabetes.

Super-Resolution Ultrasound Can Track Early Kidney Disease

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

Quadpill Strategy Gains Ground in Hypertension

Novel combinations and targeted pathway inhibitors may improve adherence and blood pressure control in patients with resistant hypertension.

Rituximab: A New Hope for Adult-Onset Nephrotic Syndrome?

Rituximab may be a safe and effective option for frequently relapsing or steroid-dependent adult-onset nephrotic syndrome, with improved relapse-free rates.

TACITO: Fecal Microbiota Transplantation Improves Immunotherapy Response in Advanced Kidney Cancer

TACITO: Fecal Microbiota Transplantation Improves Immunotherapy Response in Advanced Kidney Cancer

6 Nephrology Headlines You Missed In January 2026

6 Nephrology Headlines You Missed In January 2026

FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis

FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis

Apecotrep Delivers 40% Proteinuria Reduction in Phase 2 FSGS Trial

Apecotrep Delivers 40% Proteinuria Reduction in Phase 2 FSGS Trial

Phase 3 MODIFY Shows No Significant Renal Benefit With Lucerastat in Fabry Disease

Phase 3 MODIFY Shows No Significant Renal Benefit With Lucerastat in Fabry Disease

The HCPFive: Top News for Healthcare Providers from the Week of 01/11

The HCPFive: Top News for Healthcare Providers from the Week of 01/11

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

Latest News

Merck-Eisai's Kidney Cancer Drug Combo Fail to Improve Survival in Late-stage Trial

Merck and Eisai's experimental combination treatments failed to significantly improve survival or reduce the risk of cancer ⁠progression or death in patients with the most...

Would Earlier Initiation of Clozapine Improve FEP Outcomes?

Higher response rates with clozapine after a single treatment failure raise questions about current recommendations and whether it should be used earlier in first-episode psychosis.

Hidden Bacteria Found in Common Kidney Stones

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Showing Future Heart Risks Visually Helps Patients Manage BP

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows.

Cardiometabolic Control Elusive in Adults With Hypertension

Despite new therapies, metabolic risk hasn’t improved in more than a decade.

Low eGFR Not Associated With DKA Risk in T1D

A new study supports the use of kidney-protective medication for patients with type 1 diabetes.

Super-Resolution Ultrasound Can Track Early Kidney Disease

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

Quadpill Strategy Gains Ground in Hypertension

Novel combinations and targeted pathway inhibitors may improve adherence and blood pressure control in patients with resistant hypertension.

Rituximab: A New Hope for Adult-Onset Nephrotic Syndrome?

Rituximab may be a safe and effective option for frequently relapsing or steroid-dependent adult-onset nephrotic syndrome, with improved relapse-free rates.

TACITO: Fecal Microbiota Transplantation Improves Immunotherapy Response in Advanced Kidney Cancer

TACITO: Fecal Microbiota Transplantation Improves Immunotherapy Response in Advanced Kidney Cancer

6 Nephrology Headlines You Missed In January 2026

6 Nephrology Headlines You Missed In January 2026

FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis

FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis

Apecotrep Delivers 40% Proteinuria Reduction in Phase 2 FSGS Trial

Apecotrep Delivers 40% Proteinuria Reduction in Phase 2 FSGS Trial

Phase 3 MODIFY Shows No Significant Renal Benefit With Lucerastat in Fabry Disease

Phase 3 MODIFY Shows No Significant Renal Benefit With Lucerastat in Fabry Disease

The HCPFive: Top News for Healthcare Providers from the Week of 01/11

The HCPFive: Top News for Healthcare Providers from the Week of 01/11

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

News All Time

Age, Sex Specific eGFR Percentiles May Enable Earlier CKD Detection

Age, Sex Specific eGFR Percentiles May Enable Earlier CKD Detection

Younger Adults Face Pronounced Racial, Ethnic Gaps in Kidney Therapy

Younger Adults Face Pronounced Racial, Ethnic Gaps in Kidney Therapy

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Malnutrition Reverses Obesity Survival Advantage in Hospitalized Patients With End Stage Kidney Disease

Malnutrition Reverses Obesity Survival Advantage in Hospitalized Patients With End Stage Kidney Disease

AI-Based ZEBRA Model May Improve Detection of Fabry Nephropathy on Kidney Biopsy

AI-Based ZEBRA Model May Improve Detection of Fabry Nephropathy on Kidney Biopsy

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Diabetes, Anuria May Predict High Postvoid Residual After Kidney Transplantation

Diabetes, Anuria May Predict High Postvoid Residual After Kidney Transplantation

Global CKD Burden Projected to Rise in Young Adults and Decline in Children by 2050

Global CKD Burden Projected to Rise in Young Adults and Decline in Children by 2050

Depression's Implied Bilateral Link With Chronic Kidney Disease Progression

Depression's Implied Bilateral Link With Chronic Kidney Disease Progression

Q4 2025 Recap: Nephrology News and Updates

Q4 2025 Recap: Nephrology News and Updates

Young Adults With Glomerular Disease May Require Distinct Care

Young Adults With Glomerular Disease May Require Distinct Care

Serum Creatinine Trajectories May Predict 28-Day Mortality in CKD

Serum Creatinine Trajectories May Predict 28-Day Mortality in CKD

FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

Recommended News For You

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

Belzutifan Combo Could be Second-Line Option in Advanced RCC

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

Scientists call into question safety of potential new anticancer treatment

ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death

Recommended Articles For You

AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined 

The Importance of Having a Quick and Effective Heparin Antidote  

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells 

Unlocking the Potential of Cancer Antigen 19-9 for Early Detection 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

2.

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

3.

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

4.

Screening for prostate cancer: is it time to give up digital rectal examination?

5.

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

1.

Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection

2.

The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer

3.

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options 

4.

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence

5.

Seeing Beyond the Pink Ribbon: AI's New Battle Against Breast Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

2.

Efficient Management of First line ALK-rearranged NSCLC

3.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

4.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot